Showing results (2031-2040 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|January 7, 2021
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients-evaluation of pre-transplant risk assessmentsAntonia Pahl, Sarah Waibel, Anja Wehrle, et al.
Bone Marrow Transplantation|January 8, 2021
Characterization of readmission after allogeneic hematopoietic cell transplantationKyosuke Yamaguchi, Yoshihiro Inamoto, Kinuko Tajima, et al.
Bone Marrow Transplantation|January 9, 2021
Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantationS J M van Leeuwen, G B Proctor, A M G A Laheij, et al.
Bone Marrow Transplantation|June 1, 2021
Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMTJohanna Waidhauser, Myriam Labopin, Jordi Esteve, et al.
Bone Marrow Transplantation|June 22, 2021
Hospitalizations for vaccine-preventable infections among pediatric hematopoietic cell transplantation recipients in the first 5 years after transplantationDana Danino, Joseph R Stanek, Hemalatha Rangarajan, et al.
Bone Marrow Transplantation|June 22, 2021
A bioinspired and chemically defined alternative to dimethyl sulfoxide for the cryopreservation of human hematopoietic stem cellsRenata Gilfanova, Andrea Callegari, Adam Childs, et al.
Bone Marrow Transplantation|June 26, 2021
Itacitinib prevents xenogeneic GVHD in humanized miceJustine Courtois, Caroline Ritacco, Sophie Dubois, et al.
Bone Marrow Transplantation|December 15, 2020
Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftmentCarlos Solano, Lourdes Vázquez, Estela Giménez, et al.
Bone Marrow Transplantation|May 1, 1986
Second marrow infusion for poor graft function after allogeneic marrow transplantationG B Bolger, K M Sullivan, R Storb, et al.
Bone Marrow Transplantation|May 1, 1986
Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapseJ F Apperley, L Jones, G Hale, et al.
Pageof 993